Current Diabetes Reports

, 19:8 | Cite as

Diabetes in the Middle East: Government Health Care Policies and Strategies that Address the Growing Diabetes Prevalence in the Middle East

  • Noor Al BusaidiEmail author
  • Prakash Shanmugam
  • Deepa Manoharan
Economics and Policy in Diabetes (AA Baig and N Laiteerapong, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Economics and Policy in Diabetes


Purpose of review

Diabetes is a primary public health concern and a challenge for health decision makers in this century. Though the number of people with diabetes is increasing all over the globe, the very high prevalence of diabetes in many Middle East countries has made this region one of the global diabetes hot spots. Due to rapid socioeconomic growth, lifestyle changes and increasing obesity prevalence, the number of people with diabetes is expected to double by 2045 in this region. This high prevalence of diabetes imposes a substantial socioeconomic impact on the individual and governments in this region. The governments in the Middle East have devised many policies, programs, and strategies to address the growing prevalence of diabetes. In this article, we aim to review such policies, programs, and the magnitude of diabetes in this part of the world.

Recent findings

Faced with a challenge on a high scale, most governments in the Middle East are making progress in responding to diabetes.


Diabetes is a chronic and costly disease; however, it can be prevented. The alarm of the rising tide of diabetes has not yet been successfully translated into action in the Middle East. The governments in the region need to devise more intense, broader policies and preventive measure programs based on local sociocultural practices to effectively combat the situation. Further improvements of the primary health care system and cross-governmental approaches are needed in the region to keep the growing epidemic of diabetes under control.


Diabetes Middle East region Policy Diabetes prevention 


Compliance with Ethical Standards

Conflict of Interest

Noor Al Busaidi, Prakash Shanmugam, and Deepa Manoharan declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Badran M, Laher I Type II diabetes mellitus in arabic-speaking countries. Int J Endocrinol 2012;Article ID 902873. 11 pages.
  2. 2.
    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53. Scholar
  3. 3.
    IDF atlas, 5th Edition, 2011. Available from
  4. 4.
    •• IDF diabetes atlas 8th edition, 2017, Available from Data from IDF gives the magnitude of the problem.
  5. 5.
    Sibai AM, Semaan A, Tabbara J, Rizk A. Aging and health in the Arab region: Challenges, opportunities and the way forward. Population Horizons. 2017;14(2):AOP.
  6. 6.
    •• Alharbi NS, Alotaibi M, de Lusignan S. An analysis of health policies designed to control and prevent diabetes in Saudi Arabia. Global J Health Sci. 2016;8(11). An important article which analysis Saudi Arabia’s diabetes polices.
  7. 7.
    Elliott JA, Abdulhadi NN, Al-Maniri AA, Al-Shafaee MA, Wahlström R. Diabetes self-management and education of people living with diabetes: a survey in primary health care in Muscat Oman. Bullen C, ed. PLoS One. 2013;8(2):e57400. Scholar
  8. 8.
    • Zabetian A, Keli HM, Echouffo-Tcheugui JB, Venkat Narayan KM, Ali MK. Diabetes in the Middle East and North Africa. Diabetes Res Clin Pract. 2013;101(2):106–22. The review article gives an overview of risk factor and complications the MENA region.CrossRefPubMedGoogle Scholar
  9. 9.
    Boutayeb A, Lamlili MEN, Boutayeb W, Maamri A, et al. The rise of diabetes prevalence in the Arab region. Open Journal of Epidemiology. 2012;2:55–60. Scholar
  10. 10.
    Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes care in Iran: where we stand and where we are headed. Ann Glob Health. 2015;81(6):839–50. Scholar
  11. 11.
    Karageorgi S, Alsmadi O, Behbehani K. Prevalence, trends, risk factors, and epidemiologic methods in Kuwait. J Obes. 2013;2013:378650, 14 pages. Scholar
  12. 12.
    •• Majeed A, El-Sayed AA, Khoja T, Alshamsan R, et al. Diabetes in the middle-east and north Africa: an update. Diabetes Res Clin Pract. 103(2):218–22. This review article discusses prevalence, quality of care in ME region.
  13. 13.
    Sulaiman N, Elbadawi S, Hussein A, et al. Prevalence of overweight and obesity in United Arab Emirates Expatriates: the UAE National Diabetes and Lifestyle Study. Diabetol Metab Syndr. 2017;9:88. Scholar
  14. 14.
    Channanath AM, Farran B, Behbehani K, Thanaraj TA. State of diabetes, hypertension, and comorbidity in Kuwait: showcasing the trends as seen in native versus expatriate populations. Diabetes Care. 2013;36(6):e75. Scholar
  15. 15.
    Mabry RM, Morsi M, Owen N. Descriptive epidemiology of sitting time in omani men and women: a known risk factor for non-communicable diseases. Oman Medical Journal. 2017;32(3):233–9. Scholar
  16. 16.
    • Abu yassin B, Laher I. Diabetes epidemic sweeping the Arab world. World J Diabetes. 2016;7(8):165–74. A recent article which describes lifestyle risk factors among Arabs.CrossRefGoogle Scholar
  17. 17.
    • Al neami YM, Coleman CL. Risk factors for and barriers to control type-2 diabetes among Saudi population. Global J Health Sci. 2016;8(9):10–9. A recent study which describes barriers to diabetes control.CrossRefGoogle Scholar
  18. 18.
    Al Riyami A, Elaty MAA, Morsi M, Al Kharusi H, Al Shukaily W, Jaju S. Oman World Health Survey: Part 1 - methodology, sociodemographic profile, and epidemiology of non-communicable diseases in Oman. Oman Medical Journal. 2012;27(5):425–43.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Sulaiman N, Mahmoud I, Hussein A, et al. Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2018;6:e000489. Scholar
  20. 20.
    Behbehani K. Kuwait National Programme for healthy living: first 5-year plan (2013-2017). Med Princ Pract. 2014;23(Suppl 1):32–42. Scholar
  21. 21.
    • Al-Rubeaan K. National surveillance for type 1, type 2 diabetes and prediabetes among children and adolescents: a population-based study (SAUDI-DM). J Epidemiol Community Health. 2015;69(11):1045–51. The study explores the prevalence of diabetes among children and adolescents in Saudi Arabia which reflects many countries ME.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Alhyas L, McKay A, Balasanthiran A, Majeed A. Prevalences of overweight, obesity, hyperglycemia, hypertension, and dyslipidemia in the Gulf: a systematic review. JRSM Short Reports. 2011;2(7):55. Scholar
  23. 23.
    Moussa M, Alsaeid M, Abdella N, et al. Prevalence of type 2 diabetes mellitus among Kuwaiti children and adolescents. Med Princ Pract. 2008;17:270–5. Scholar
  24. 24.
    Al-Hazzaa HM, Abahussain NA, Al-Sobayel HI, Qahwaji DM, Alsulaiman NA, Musaiger AO. Prevalence of overweight, obesity, and abdominal obesity among urban Saudi adolescents: gender and regional variations. J Health Popul Nutr. 2014;32(4):634–45.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Qatar National Health Strategy 2018-2022. Available from
  26. 26.
    Al Dhaifallah A, Mwanri L, Aljoudi A. Childhood obesity in Saudi Arabia: opportunities and challenges. Saudi Journal of Obesity. 2015;3(1):2–7. Scholar
  27. 27.
    Aljunaibi A, Abdulle A, Nagelkerke N. Parental weight perceptions: a cause for concern in the prevention and management of childhood obesity in the United Arab Emirates. Schooling CM, ed. PLoS One. 2013;8(3):e59923. Scholar
  28. 28.
    Alaslani MH, Alasmari MAS, Almaghamsi AH, Mufti MI, et al. Obesity in children and its connection to diabetes in Saudi Arabia: review. Int J Med Res Prof. 2018;4(1):349–54. Scholar
  29. 29.
    Al-Shafaee M, Al-Farsi Y, Al-Kaabi Y, Banerjee Y, Al-Zadjali N, Al-Zakwani I. Quality of diabetes care in primary health centres in north Al-Batinah of Oman. Open Cardiovasc Med J. 2014;8:48–54. Scholar
  30. 30.
    Khoja T, Rawaf S, Qidwai W, Rawaf D, Nanji K, Hamad A. Health care in Gulf Cooperation Council countries: a review of challenges and opportunities. Muacevic A, Adler JR, eds. Cureus. 2017;9(8):e1586. Scholar
  31. 31.
    Al-Rubeaan K. The impact of diabetes mellitus on health and economy of Gulf Cooperation Council countries. Diabetes Manage. 2014;4:381–90.CrossRefGoogle Scholar
  32. 32.
    Alhyas L, McKay A, Balasanthiran A, Majeed A. Quality of type 2 diabetes management in the states of the Co-Operation Council for the Arab States of the Gulf: a systematic review. Sesti G, ed. PLoS One. 2011;6(8):e22186. Scholar
  33. 33.
    Szabo SM, Osenenko KM, Qatami L, Korenblat Donato BM, et al. Quality of care for patients with type 2 diabetes mellitus in Dubai: a HEDIS-like assessment. Int J Endocrinol. 2015;2015:413276, 8 pages. Scholar
  34. 34.
    • Al-Sinani S, Al-Mamari A, Woodhouse N, et al. Quality of diabetes care at outpatient clinic, Sultan Qaboos University Hospital. Oman Medical Journal. 2015;30(1):48–54. Gives an over of diabetes care quality in a teaching hospital.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Noor Abdulhadi NM, Al-Shafaee MA, Wahlström R, Hjelm K. Doctors’ and nurses’ views on patient care for type 2 diabetes: an interview study in primary health care in Oman. Prim Health Care Res Dev. 2013;14(3):258–69. Scholar
  36. 36.
    Alhyas L, Nielsen JDJ, Dawoud D, Majeed A. Factors affecting the motivation of healthcare professionals providing care to Emiratis with type 2 diabetes. JRSM Short Reports. 2013;4(2):14. Scholar
  37. 37.
    • P Mohammed, J. Alramadan, Afsana Afroz, Sultana Monira Hussain, Mohammed Ali Batais et al. Patient-related determinants of glycaemic control in people with type 2 diabetes in the Gulf Cooperation Council countries: a systematic review. J Diabetes Res. 2018;2018:Article ID 9389265, 14 pages A recent review describes modifiable and nonmodifiable risk factors for suboptimal glycemic control in GCC.
  38. 38.
    Al-Baharna MM, Whitford DL. Clinical audit of diabetes care in the Bahrain Defence Forces Hospital. Sultan Qaboos Univ Med J. 2013;13(4):520–6.CrossRefGoogle Scholar
  39. 39.
    Al-Busaidi IS, Abdulhadi NN, Coppell KJ. Care of patients with diabetic foot disease in Oman. Sultan Qaboos Univ Med J. 2016;16(3):e270–6. Scholar
  40. 40.
    American Diabetes Association. The cost of diabetes. Available at:
  41. 41.
    van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(Suppl 1):S1–8. Scholar
  42. 42.
    • WHO global report on diabetes 2016, available at -, WHO report discusses various aspects of global diabetes, including national policies, guidelines, and protocols.
  43. 43.
    • Al-Maskari F, El-Sadig M, Nagelkerke N. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates. BMC Public Health. 2010;10:679. An article gives an idea about cots of diabetes in one of the countries in ME.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Elrayah-Eliadarous H, Yassin K, Eltom M, Abdelrahman S, et al. Direct costs for care and glycaemic control in patients with type 2 diabetes in Sudan. Exp Clin Endocrinol Diabetes. 2010;118(4):220–5. Scholar
  45. 45.
    Afaf MS, Al-Adsani, Kholouda A. Abdulla Reasons for hospitalizations in adults with diabetes in Kuwait. International Journal of Diabetes Mellitus. 2015:65–9.Google Scholar
  46. 46.
    Mirghani Dirar A, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017;8(12):489–511. Scholar
  47. 47.
    Alfadhli EM, Osman EN, Basri TH, et al. Gestational diabetes among Saudi women: prevalence, risk factors, and pregnancy outcomes. Annals of Saudi Medicine. 2015;35(3):222–30. Scholar
  48. 48.
    Alshaikh MK, Filippidis FT, Al-Omar HA, Rawaf S, et al. The ticking time bomb in lifestyle-related diseases among women in the Gulf Cooperation Council countries; review of systematic reviews. BMC Public Health. 2017;17:536. Scholar
  49. 49.
    World Health Organization. Women and health: today's evidence tomorrow's agenda, available at
  50. 50.
    • Ministry of Health Oman. Nizwa healthy lifestyle evaluation report. Muscat, Oman: Ministry of Health. 2012. Available online at A report which gives an idea about how cross-governmental approach can improve the lifestyle of the community
  51. 51.
    •• Faraji O, Etemad K, Sari AA, Ravaghi H. Policies and programs for prevention and control of diabetes in Iran: a document analysis. Global J Health Sci. 2015;7(6):187–97. A review article discusses Iran’s diabetes program.CrossRefGoogle Scholar
  52. 52.
    Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract. 2014;103(2):319–27. Scholar
  53. 53.
  54. 54.
    WHO, the Riyadh declaration on September 12, 2012, available at
  55. 55.
    •• IDF global diabetes scorecard, available at IDF source which gives an overview of diabetes programs in each country
  56. 56.
    Early Action in Diabetes: United Arab Emirates Policy Road-Map, available at
  57. 57.
    Alyaarubi S. Diabetes care in Oman: obstacles and solutions. Sultan Qaboos Univ Med J. 2011;11(3):343–8.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Al-Sinani M, Min Y, Ghebremeskel K, Qazaq HS. Effectiveness of and adherence to dietary and lifestyle counselling: effect on metabolic control in type 2 diabetic Omani patients. Sultan Qaboos Univ Med J. 2010;10(3):341–9.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 Diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411–7. Scholar
  60. 60.
    Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ. 2005;31(4):564–71. Scholar
  61. 61.
    Ghadiri-Anari A, Fazaelipoor Z, Mohammadi SM. Insulin refusal in Iranian patients with poorly controlled type 2 diabetes mellitus. Acta Med Iran. 2013;51(8):567–71.PubMedGoogle Scholar
  62. 62.
    •• Al-Shudifat A-E, Al-Shdaifat A, Al-Abdouh AA, et al. Diabetes risk score in a young student population in Jordan: a cross-sectional study. J Diabetes Res. 2017;2017:8290710. A recent article estimates diabetes risk factors among younger population and assesses the usefulness of Finnish diabetes risk score among them.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    •• Alva ML. A review of the impacts of different approaches for diabetes prevention and a framework for making investment decisions. Int J Environ Res Public Health. 2018;15(3):522. A recent paper which discusses individual and population level interventions.CrossRefPubMedCentralGoogle Scholar
  64. 64.
    Crandall JP, Knowler WC, Kahn SE, et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2008;4(7):382–93. Scholar
  65. 65.
    Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86. Scholar
  66. 66.
    Aziz Z, Absetz P, Oldroyd J, Pronk NP, Oldenburg B. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015;10:172. Scholar
  67. 67.
    Dunkley AJ, Bodicoat DH, Greaves CJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37(4):922–33. Scholar
  68. 68.
    Woolf SH, Husten CG, Lewin LS, Marks JS, Fielding JE, Sanchez EJ. The economic argument for disease prevention: distinguishing between value and savings. Washington, DC: Partnership for Prevention; 2009. available at Google Scholar
  69. 69.
    Hamidi S. Health services financing and delivery: analysis of policy options for Dubai, United Arab Emirates. ClinicoEconomics and Outcomes Research: CEOR. 2015;7:133–43. Scholar
  70. 70.
    • El-Jardali F, Ataya N, Jamal D, Jaafar M. A multi-faceted approach to promote knowledge translation platforms in eastern Mediterranean countries: climate for evidence-informed policy. Health Research Policy and Systems. 2012;10:15. Discuss the engagement of knowledge transfer activities among policymakers and the need for evidence-based structured policy making.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    World Health Organization –country profiles. 2016. Available at

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Noor Al Busaidi
    • 1
    Email author
  • Prakash Shanmugam
    • 1
  • Deepa Manoharan
    • 1
  1. 1.National Diabetes and Endocrine CentreRoyal HospitalMuscatSultanate of Oman

Personalised recommendations